The new plant will be situated in the Special Economic Zone in East Java JIIPE, Indonesia, focusing on biologics.

AI-DR is the world's first AI-powered software that identifies DR by types, stages and lesions- all at the same time.  

TCI acquires a manufacturing facility from US-based NewAge and strikes a long-term deal with the company for manufacturing and global expansion

VeriSee has been approved by Thailand and Indonesia's FDA, with aims at market expansion in Asia

P1101, a new drug developed by PharmaEssentia, which targets the rare disease myeloproliferative neoplasms (MPNs), is now featuring on BBC StoryWorks

A domestic production of one type of rapid coronavirus test kits for use at home has been approved by Taiwan FDA

The nasal swab test provides results within 24 hours after samples arrive at Amazon's labs

Those who test positive asked to get second test at designated screening center

A drug candidate developed by Golden Biotechnology Corp. of COVID-19 will be administered to seriously ill patients in its Phase II clinical trials in the United States, awaiting authorisation by the relevant authorities.

The service provides remote care via video conferencing or telephone, targets outpatients with chronic diseases or people in need of outpatient services. (Photo courtesy of Taipei Medical University Hospital)

The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants.

Booth selection rescheduled on 15 June for exhibitors with 6+ booths and 30 July for others.

Guardant Health liquid biopsy test and Qiagen’s tissue-based test receive FDA approval as CDx for Lumakras. Photo credit: Ajale from Pixabay)

The system will help doctors to read chest X-rays and thus more quickly detect COVID-19 infections.

Tech giant expands health-sector presence in latest deal to develop tools to improve medical care, as privacy concerns arise.

Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U.S. Commercialization

The approval aids in the country’s emergency of acute liposomal amphotericin B shortage.

Adimmune Corp. will be introducing vaccines for influenza, tetanus and enterovirus into Southeast Asian markets in the initial stage, once the joint venture has been established.

Strategies by IBMI to address issues flagged by healthcare providers and around panic of getting infected.